Table 3. The use of antidiabetic medications (%) among people with diagnosed type 2 diabetes mellitus.
| 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Insulin | 8.6 | 9.5 | 11.5 | 14.8 | 17.3 | 18.7 | 19.1 | 18.6 | 17.8 | 17.6 | 17.3 | 16.4 |
| SU | 87.2 | 86.2 | 85.5 | 84.3 | 82.9 | 81.5 | 80.0 | 76.7 | 70.7 | 66.2 | 62.1 | 58.5 |
| Metformin | 52.9 | 56.6 | 59.0 | 59.7 | 60.9 | 62.9 | 64.9 | 68.9 | 72.3 | 76.9 | 79.1 | 80.4 |
| Glinide | 1.0 | 2.9 | 3.5 | 4.1 | 5.0 | 6.1 | 6.3 | 5.4 | 4.8 | 3.6 | 2.6 | 2.0 |
| TZD | 7.3 | 9.4 | 10.5 | 11.0 | 11.5 | 10.7 | 11.4 | 13.0 | 11.2 | 8.2 | 6.6 | 6.5 |
| DPP-4i | - | - | - | - | - | - | 0.3 | 8.4 | 13.9 | 19.0 | 28.7 | 38.4 |
| α-GI | 24.3 | 24.4 | 23.0 | 22.0 | 23.9 | 24.4 | 24.6 | 22.8 | 21.4 | 18.5 | 13.4 | 9.4 |
| Total | 181.3 | 189.0 | 193.0 | 196.0 | 201.5 | 204.4 | 206.6 | 213.7 | 212.0 | 210.1 | 209.8 | 211.7 |
SU, sulfonylurea; TZD, thiazolidinedione; DPP-4i, dipeptidyl peptidase-4 inhibitor; α-GI, α-glucosidase inhibitor.